RecruitingPhase 2NCT05839535

Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA

Enhancing Modulation Effects of Baduanjin Through Non-invasive Neuromodulation for Knee Osteoarthritis

Sponsor

Massachusetts General Hospital

Enrollment

140 participants

Start Date

Mar 5, 2024

Study Type

INTERVENTIONAL

Conditions

Knee Osteoarthritis

Summary

This study will combine brain imaging and neuromodulation tools to investigate the underlying neurobiological mechanisms of exercises. The findings will enhance our understanding of the mechanisms underlying mind-body exercise and facilitate the development of new pain management approaches.

Eligibility

Min Age: 45 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called BDJ, exercise, and others for people with knee osteoarthritis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 45 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.